EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.14.16.4 | tryptophan 5-monooxygenase |
prefrontal cortex |
expression of the native truncated mutant TPH2 |
689089 |
1.3.1.22 | 3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) |
prefrontal cortex |
similar 5alpha-R1 mRNA expression in female and male rats, 5alpha-R2 mRNA expression significantly higher in females than in males |
676162 |
1.4.3.1 | D-aspartate oxidase |
prefrontal cortex |
- |
742426 |
2.1.1.6 | catechol O-methyltransferase |
prefrontal cortex |
- |
702948, 705937 |
2.3.1.6 | choline O-acetyltransferase |
prefrontal cortex |
in both young adult and middle-aged animals, oestradiol treatment initiates immediately after ovariectomy significantly increased ChAT levels in the hippocampus but not in the prefrontal cortex compared to cholesterol control treatment. When oestradiol treatment is initiated 5 months after ovariectomy, it fails to significantly increase ChAT levels in the hippocampus, but does so in the prefrontal cortex |
688529 |
2.3.3.1 | citrate (Si)-synthase |
prefrontal cortex |
- |
720443, 720554 |
2.7.1.137 | phosphatidylinositol 3-kinase |
prefrontal cortex |
cocaine sensitization increases PI3K activity. The changes are not normalized following the reversal of cocaine-sensitization |
671736 |
2.7.11.16 | G-protein-coupled receptor kinase |
prefrontal cortex |
- |
738580 |
2.7.3.2 | creatine kinase |
prefrontal cortex |
- |
705502 |
2.7.3.2 | creatine kinase |
prefrontal cortex |
creatine kinase activity is inhibited in prefrontal cortex and hippocampus of rats 12 h after renal ischemia. The treatment with antioxidants prevents such effect |
689220 |
2.7.7.6 | DNA-directed RNA polymerase |
prefrontal cortex |
- |
705928 |
3.4.11.21 | aspartyl aminopeptidase |
prefrontal cortex |
- |
663814 |
3.4.11.3 | cystinyl aminopeptidase |
prefrontal cortex |
cystinyl aminopeptidase is 100% higher in the left than in the right prefrontal cortex |
663814 |
3.4.11.7 | glutamyl aminopeptidase |
prefrontal cortex |
highest activity |
699650 |
3.4.17.10 | carboxypeptidase E |
prefrontal cortex |
- |
683798 |
3.4.17.21 | Glutamate carboxypeptidase II |
prefrontal cortex |
- |
701206 |
3.4.17.21 | Glutamate carboxypeptidase II |
prefrontal cortex |
withdrawal of 3,4-methylenedioxypyrovalerone reduces expression of glutamate carboxypeptidase II in the prefrontal cortex |
755361 |
3.4.21.68 | t-Plasminogen activator |
prefrontal cortex |
- |
707932 |
3.4.21.94 | proprotein convertase 2 |
prefrontal cortex |
- |
709603 |
3.5.1.4 | amidase |
prefrontal cortex |
- |
690174 |
4.1.1.15 | glutamate decarboxylase |
prefrontal cortex |
orbitofrontal, anterior cingulate, and dorsolateral |
698395 |
4.1.1.17 | ornithine decarboxylase |
prefrontal cortex |
- |
677922 |
4.1.1.19 | arginine decarboxylase |
prefrontal cortex |
- |
694355 |
4.1.1.19 | arginine decarboxylase |
prefrontal cortex |
significantly increased agmatine levels in the prefrontal, entorhinal, and perirhinal cortices in a T-maze training group relative to the control group |
692560 |
7.1.1.9 | cytochrome-c oxidase |
prefrontal cortex |
- |
689159 |